NCT05585580 2026-05-26Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior ImmunotherapyQilu Hospital of Shandong UniversityPhase 2 Active not recruiting59 enrolled